• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

AXA Framlington Biotech Fund Z Acc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider AXA Investment Managers UK Ltd
Fund Summary The aim of this Fund is to provide long-term capital growth.
SEDOL code B784NS1
ISIN GB00B784NS11
Fund code FMBTA
Managers Linden Thomson, Dani Saurymper
Manager Tenure 8 years
Morningstar Category Sector Equity Biotechnology
IMA Sector Specialist
Fund Size £377 million
Fund Type OEIC
Management Style Active
Ongoing Charge Figure (OCF) 0.82%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £3.6350
Buy Price £3.6350
Price Change -5.0913%
Price Date 8th April 2020
Yield Currently unavailable
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 29th May 2013
Fund Status OPEN

3-year Mean Monthly Return: 0.525%

Annual Returns 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund Performance +3.13% +10.45% +0.38% +30.53% -26.70% +74.29% +33.86% +34.90% +23.36% -2.59%
Benchmark Performance
(Sector Equity Biotechnology)
-0.43% +8.06% -2.35% +32.54% -22.76%
Time Period Cumulative Benchmark Performance
(Sector Equity Biotechnology)
Fund Compared to Benchmark
1 day -5.09% -2.92% -2.17%
1 week 5.61% -3.00% +8.60%
1 month 0.69% -3.02% +3.71%
3 months 2.48% +11.34% -8.86%
6 months 15.62% -0.66% +16.28%
1 year -0.60% +5.49% -6.09%
3 years 5.84% +4.18% +1.66%
5 years 2.98% +14.10% -11.12%
10 years 15.55% +7.32% +8.23%
YTD 2.34% +4.54% -2.20%
Since inception 8.24% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Biogen Inc USA 8.52%
Amgen Inc USA 8.00%
Regeneron Pharmaceuticals Inc USA 6.60%
Gilead Sciences Inc USA 6.45%
Alexion Pharmaceuticals Inc USA 5.05%
Vertex Pharmaceuticals Inc USA 4.37%
Biomarin Pharmaceutical Inc USA 4.20%
Seattle Genetics Inc USA 3.36%
Incyte Corp USA 2.89%
Illumina Inc USA 2.70%

Currently unavailable